AIDS-Related Mycoses in the Paediatric Population
Purpose of Review
Fungal infections account for significant morbidity and mortality in HIV-infected children particularly in developing countries where there is lack of skilled personnel and infrastructure to make the appropriate diagnosis. This is further compounded by poor availability and accessibility of the antifungals needed to treat these infections. The purpose of this review is to highlight the paucity of data on AIDS-related mycoses in the paediatric age group and make appropriate recommendations to address challenges associated with mycoses in this population.
These infections are categorised in two broad groups in this population: mucocutaneous, which commonly affects nutrition and adherence to therapy and invasive fungal infections which are life-threatening. A literature search revealed a total of 29 published literatures across all AIDS-related mycoses in the paediatric population.
Research to determine the true burden of the problem and greater funding with implementation of a package of care that will result in substantial reductions in morbidity and mortality in relation to AIDS-related mycoses in children are needed. It is imperative that the programmatic optimal package of care for children with advanced HIV disease is designed and implemented.
KeywordsMycoses Paediatric Advanced HIV disease HIV/AIDS LMICs
Compliance with Ethical Standards
Conflict of Interest
Bassey Ekeng, Omosalewa Olusoga and Rita Oladele declare no conflicts of interest relevant to this manuscript.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.• Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, et al. Managing advanced HIV disease in a public health approach. Clin Infect Dis. 2018;66(S2):S106–10 This is a review article that highlights the challenges of opportunistic infections with advanced HIV disease.PubMedPubMedCentralCrossRefGoogle Scholar
- 2.•• Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. This is the current guidelines for diagnosing, therapeutic and preventive management of opportunistic infections in advanced HIV disease. Google Scholar
- 5.•• Frigati L, Archary M, Rabie H, Penazzato M, Ford N. Priorities for decreasing morbidity and mortality in children with advanced HIV disease. Clin Infect Dis. 2018;66(S2):S147–S51 Very important review highlighting the knowledge gaps, offering possible solutions and challenging the status quo. PubMedPubMedCentralCrossRefGoogle Scholar
- 16.Leibovitz E, Rigaud M, Chandwani S, et al. Disseminated fungal infections in children infected with human immunodeficiency virus. Paediatr Infect Dis J. 1991;10(12):888–94.Google Scholar
- 25.Karstaedt AS. AIDS-the Baragwanath experience. Part 111. HIV infection in adults at Baragwanath Hospital. South African Med. 1992;82(2):95–7.Google Scholar
- 32.Nathoo K, Gondo M, Gwanzura L, Mhlanga B, Mavetera T, Mason P. Fatal Pneumocystis carinii pneumonia in HIV-seropositive infants in Harare, Zimbabwe. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2001;95:37–9. https://doi.org/10.1016/S0035-9203(01)90325-6.CrossRefPubMedGoogle Scholar
- 35.Masur H, Kaplan JE, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons—2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. In: The Morbidity and Mortality Weekly Report Recommendations and Reports; 2002, Jun 12:51(RR-8). p. 1–52.Google Scholar
- 37.Lanaspa M, Callaghan-Gordo CO, Machevo S, Madrid L, Nhampossa T, Acácio S, et al. High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children < 5 years of age admitted to hospital with clinical severe pneumonia, Clinical Microbiology and Infection. 2015;21:1018.e9–1018.e15. https://doi.org/10.1016/j.cmi.2015.07.011.PubMedCrossRefPubMedCentralGoogle Scholar
- 38.• Lowe DM, Rangaka MX, Gordon F, James CD, et al. Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systemic review and meta-regression. Plos one. 2013;8(8):e69969 This systematic review is focussed on resource-limited settings where the highest burden of advanced HIV disease is and it addresses PCP which is an AIDS defining infection. PubMedPubMedCentralCrossRefGoogle Scholar
- 39.•• Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf. This panel focussed exclusively on OIs in advanced HIV disease in children; it proffers evidenced-based guidelines for management.
- 41.Onishi A, Sugiyama D, et. al. Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis jirovecii pneumonia, invasive candidiasis, and invasive aspergillosis: systemic review and meta-analysis. J Clin Microbiol2012;50(1), 7-15Google Scholar
- 43.Jay Koll AIDS mycoses meeting, Cape Town, 2019Google Scholar
- 44.• Meiring ST, Quan VC, Cohen C, Dawood H, Karstaedt AS, McCarthy KM, et al. A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005–2007. AIDS 2012, 26:2307–2314. This study highlights the low rates of cryptococcosis in the paediatric population. PubMedCrossRefGoogle Scholar
- 45.Anígilájé EA, Olutola A, Dabit O, Adeoti AO, Emebolu AJ, et al. There is no cryptococcal antigenaemia among a cohort of children with advanced HIV infection in an antiretroviral therapy programme in Makurdi, Nigeria. J AIDS Clin Res. 2013;4:261. https://doi.org/10.4172/2155-6113.1000261.CrossRefGoogle Scholar
- 46.Ezeanolue EE, Nwizu C, Greene GS, Amusu O, Chukwuka C, Ndembi N, et al. Geographical variation in prevalence of cryptococcal antigenemia among HIV-infected treatment-naïve patients in Nigeria: a multicenter cross-sectional study. Journal of acquired immune deficiency syndromes. 2016;1;73(1):117.CrossRefGoogle Scholar
- 61.Cherian T, Ramakrishna B, Babu PG, John TJ, Raghupathy P. Pneumocystis carinii pneumonia in pediatric acquired immuno-deficiency syndrome. Indian Paediatr, Vol. 1997:34.Google Scholar
- 70.Crump JA, Ranadhani HO, Morrissey AB, Saganda W, Mwako MS, Yang LY, et al. Invasive funfal and bacterial infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania. Clin Infect Dis. 2011;1:52(3):341–8. https://doi.org/10.1093/cid/ciq103.CrossRefPubMedGoogle Scholar
- 73.Alverson B, Alexander N, LeGolvan MP, Dunlap W, Levy C. A human immunodeficiency virus-positive infant with probable congenital histoplasmosis in a nonendemic area. Paediatr Infect Dis J. 2010;29(11):1055–7.Google Scholar